; Whereas because of the way meningococcal disease is spread through close personal contact, the social behavior of young adults ages 16 to 23 increases the risk of those adults contracting the disease; Whereas students in dormitory settings and at crowded events are particularly vulnerable to meningococcal disease; Whereas college students ages 18 to 24 were found to be 3.5 times more likely to contract meningitis B, the strain of meningococcal disease caused by serogroup B, compared to their peers not in school; Whereas the single best way to help prevent all common strains of meningococcal disease is to be vaccinated with— (1) a MenACWY vaccine to protect against the strains of meningococcal disease caused by serogroups A, C, W, and Y; and (2) a separate MenB vaccine to protect against the strain of meningococcal disease caused by serogroup B; Whereas the incidence of meningococcal disease in the United States incidence has steadily declined since 1995 (1.20 cases/100,000 persons) to a historic low of 0.11 cases/100,000 persons in 2017; Whereas although vaccines for serogroups A, C, W, and Y have been available for many years, a vaccine for serogroup B was not available until 2014; Whereas despite the existence of a vaccine for serogroup B since 2014, meningitis B has been responsible for all United States college campus outbreaks since 2011, with some cases resulting in death; Whereas because the strain of meningococcal disease caused by serogroup B requires a new, separate vaccination, students heading to college may mistakenly think that, if they received the MenACWY vaccine, they are protected against all strains of the disease, and may not realize that they are not protected against the strain caused by serogroup B; Whereas according to the Centers for Disease Control and Prevention, Neisseria meningitidis serogroup B accounts for approximately half of all cases of meningococcal disease among individuals ages 15 to 22 in the United States